A new, safe and resistance-free treatment of vaginal fungal and bacterial infections

Important results from the project

The main aim of the project was to conduct a clinical study to investigate symptom improvement, user experience and treatment effect in patients with vaginal yeast infection with the new tablet formulation. The clinical study showed very positive results for the treatment of fungal infection in the 26 patients. The users rated the treatment as easy and gentle to use and were generally very satisfied. The intention of the study, to show the effect of a new formulation for the treatment of vaginal fungal infection, and the study´s primary objective, has thus been fulfilled.

Expected long term effects

The project´s objective have been met as we have completed the clinical study for the treatment of vaginal fungal infection with the new tablet formulation. The clinical study showed that the treatment is both efficient and safe for treatment of ongoing vaginal yeast infection, that the patients experienced symptom reduction and that the product is user-friendly and gentle. The market survey gave us important information about the patients´ level of knowledge and treatment preferences.

Approach and implementation

A clinical study has been conducted, where 26 patients with clinically verified vaginal yeast infection have been treated with pHyph for 6 days. Four clinics in Gothenburg, Stockholm and Uppsala recruited the patients. During the project, a market study was also carried out via social media, where almost 100 patients participated in a survey to give us more information about the level of knowledge about the vaginal microbiome and how patients choose treatments.

External links

Bolagets webbsida